logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Mafalda Oliveira

vall d'hebron university hospital
H指数:48
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Body Mass Index in Postmenopausal Women with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer: An Exploratory Analysis of the LORELEI trial.

雌激素受体阳性、HER2阴性早期乳腺癌绝经后女性中的体重指数：LORELEI试验的探索性分析

European Journal of Cancer
IF7.1
2026-06-120
PRE
Chiara Dauccia; Maria Alice Franzoi; Cristina Saura; Dominik Hlauschek; Lidija Sölkner; Michael Gnant; Peter C. Dubsky; Ruth Helfgott; Gabriele Zoppoli; Mafalda Oliveira; Laetitia Collet; Jill Fredrickson; Timothy R. Wilson; Luca Arecco; Elisa Agostinetto; Evandro de Azambuja
Evolving landscape of targeted therapies in early phase clinical trials

靶向疗法在早期临床试验中的演变格局

European Journal of Cancer
IF7.1
2026-04-120
PRE
Alice Rossi; Irene Braña; Maria Vieito; Oriol Mirallas; Victor Navarro; Omar Saavedra; Guzman Alonso Casal; Vladimir Galvao; M Julia Lostes Bardaji; Arjun Oberoi; Giulia Pretelli; Marta Sanz; Sergio Andres Bueno; Benet Fite Abril; Susana Aguilar Izquierdo; Jose Jimenez; Paolo Nuciforo; Ana Vivancos; Mafalda Oliveira; Iosune Baraibar
Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO)

talimogene laherparepvec和atezolizumab在HER2阴性乳腺癌新辅助化疗后的应用：一项窗口期II期试验（SOLTI-1503 PROMETEO）

Nature Communications
IF15.7
2026-02-160
OA
Tomás Pascual; Maria Vidal; Juan M. Cejalvo; Estela Vega; Esther Sanfeliu; Guillermo Villacampa; Sergi Ganau; Ana María Julve Parreño; Esther Zamora; Ignacio Miranda; Ana Delgado; Begoña Bermejo; Elia Seguí; Fara Brasó-Maristanty; Luis de la Cruz-Merino; Manel Juan; Patricia Galván; Xavier Gonzàlez-Farré; Samyukta Chillara; Patricia Villagrasa; Adam D. Pfefferle; Constandina E. O’Connell; Juan M. Ferrero-Cafiero; Mafalda Oliveira; Charles M. Perou; Aleix Prat
Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1☆

Camizestrant联合capivasertib治疗ER阳性，HER2-negative晚期乳腺癌的女性: SERENA-1 ☆ 的结果

ESMO Open
IF8.3
2026-01-210
OAAI
C. Vaklavas; M. Oliveira; A.C. Armstrong; I. Moreno; C. Twelves; I. Victoria Ruiz; B. Bermejo de las Heras; T. Brier; C. Ciardullo; L. Gibbons; T. Jack; T. Klinowska; J.P.O. Lindemann; A.M. Mathewson; R. Maudsley; C.J. Morrow; A. Sykes; R.D. Baird
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis

内分泌为基础的策略在激素受体阳性晚期乳腺癌生物标志物选择亚组中CDK4/6抑制剂后的应用：一项系统评价和网络Meta分析

Cancer Treatment Reviews
IF10.5
2025-12-030
PRE
Alicia Escudero; Meritxell Bellet; Cristina Saura; Anna Aguilera; Andri Papakonstantinou; Pablo Tolosa; José Ángel García-Sáenz; Fernando Moreno; Alfonso López de Sá; Francesco Schettini; Elia Seguí; Marta Gonzalez-Rodriguez; Victor Navarro; Juan Manuel Ferrero-Cafiero; Xavier González; Cristina Hernando; Alexios Matikas; Aleix Prat; Mafalda Oliveira; Tomas Pascual
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial

帕博西利和曲妥珠单抗用于HER2阳性转移性乳腺癌：SOLTI-1303-PATRICIA试验A组和B组的最终总生存结果

ESMO Open
IF8.3
2025-09-010
OAAI
T. Pascual; G. Villacampa; M. Oliveira; S. Escrivá-de-Romaní; S. Pernas; L. Paré; B. Adamo; E. Martínez; J. Cortés; A. Perelló; M. Galan; M. Melé; L. Villanueva; M. Gonzalez-Rodriguez; P. Tolosa; B. González-Farré; P. Galván; J. Canes; P. Nuciforo; J.M. Ferrero-Cafiero; X. González-Farré; P. Villagrasa; A. Prat; E. Ciruelos
Identifying germline pathogenic variants in breast cancer using tumor sequencing

通过肿瘤测序鉴定乳腺癌中的生殖系致病性变异

BREAST
IF7.9
2025-06-010
OAAI
Cruellas, Mara; Papakonstantinou, Andri; Lopez-Fernandez, Adria; Castillo, Ester; Matito, Judit; Gomez, Marina; Rezqallah, Alejandra; Vega, Sharela; Navarro, Victor; Torres, Maite; Moles-Fernandez, Alejandro; Saura, Cristina; Vivancos, Ana; Balmana, Judith; Oliveira, Mafalda
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer

TROPION-Breast05：一项关于Dato-DXd联合或不联合durvalumab与化疗联合pembrolizumab治疗PD-L1高表达局部复发不可手术或转移性三阴性乳腺癌的随机III期研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-04-170
OA
Peter Schmid; Mafalda Oliveira; Joyce O’Shaughnessy; Massimo Cristofanilli; Stephanie L. Graff; Seock-Ah Im; Sherene Loi; Shigehira Saji; Shusen Wang; David W. Cescon; Tina Hovey; Agata Nawrot; Karson Tse; Petra Vukovic; Giuseppe Curigliano
A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancer

CAPItello-291研究的简明语言摘要: 激素受体阳性的晚期乳腺癌中的Capivasertib

FUTURE ONCOLOGY
IF2.6
2024-09-162
OAAI
Turner, Nicholas C.; Oliveira, Mafalda; Howell, Sacha J.; Dalenc, Florence; Cortes, Javier; Gomez, Henry L.; Hu, Xichun; Jhaveri, Komal; Krivorotko, Petr; Loibl, Sibylle; Murillo, Serafin Morales; Park, Yeon Hee; Sohn, Joo-Hyuk; Toi, Masakazu; Tokunaga, Eriko; Yousef, Samih; Zhukova, Lyudmila; de Bruin, Elza; Grinsted, Lynda; Schiavon, Gaia; Foxley, Andrew; Rugo, Hope S.
Interim analysis (IA) of the giredestrant (G) plus samuraciclib (SAMURA) arm in MORPHEUS breast cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC)

MORPHEUS乳腺癌（BC）研究中，giredestrant（G）联合samuraciclib（SAMURA）组的期中分析（IA）：一项在雌激素受体阳性（ER+）、HER2阴性、局部晚期/转移性乳腺癌（LA/mBC）患者中评估G治疗方案组合的I/II期研究。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Oliveira, M.; Gion Cortes, M.; Jung, K. H.; Bermejo, B.; Hurvitz, S. A.; Sadeghi, S.; Wander, S.; Im, S-A.; Gal-Yam, E.; Zhu, J.; Schwab, R.; Ngo, H.; Collier, A.; Cannon, M.; Cahuzac, C.; Moreno, P. D. Perez; Mcintosh, S.; Saavedra Serrano, C.; Sonnenblick, A.
Ipatasertib plus Paclitaxel for Patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial
CLINICAL CANCER RESEARCH
IF10.2
2024-07-260
OAAI
Dent, Rebecca A.; Kim, Sung-Bae; Oliveira, Mafalda; Barrios, Carlos; O'Shaughnessy, Joyce; Isakoff, Steven J.; Saji, Shigehira; Freitas-Junior, Ruffo; Philco, Manuel; Bondarenko, Igor; Lian, Qinshu; Bradley, Denise; Hinton, Heather; Wongchenko, Matthew J.; Reilly, Sarah-Jayne; Turner, Nicholas
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
NATURE COMMUNICATIONS
IF15.7
2024-07-111
OAAI
Braso-Maristany, Fara; Ferrero-Cafiero, Juan Manuel; Falato, Claudette; Martinez-Saez, Olga; Cejalvo, Juan Miguel; Margeli, Mireia; Tolosa, Pablo; Salvador-Bofill, Francisco Javier; Cruz, Josefina; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Odena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana Maria; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sanchez-Bayona, Rodrigo; Ciruelos, Eva; Espinosa-Bravo, Martin; Izarzugaza, Yann; Galvan, Patricia; Matito, Judith; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-Dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomas; Prat, Aleix; Oliveira, Mafalda
Characterizing Immune Infiltration in Metastatic Hormone Receptor-Positive/HER2Negative Breast Cancer: A Comprehensive Translational Analysis from four SOLTI Clinical Trials
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Segui, Elia; Sanfeliu, Esther; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Salvador, Fernando; Angelats, Laura; Villanueva, Lorea; Espinosa, Alejandra; Galvan, Patricia; Fernandez, Esther; Gonzalez-Farre, Xavier; Escriva-De-Romani, Santiago; Chic, Nuria; Ciruelos, Eva; Saura, Cristina; Manso, Luis; Oliveira, Mafalda; Tabernero, Josep; Prat, Aleix; Pascual, Tomas
Capivasertib and fulvestrant for patients with aromatase inhibitor-resistant HR positive/HER2-negative advanced breast cancer: exploratory analysis of PFS by AKT pathway gene from the Phase 3 CAPItello-291 trial
CANCER RESEARCH
IF16.6
2024-05-021
PRE
Howell, Sacha; Rugo, Hope; Oliveira, Mafalda; Dalenc, Florence; Cortes, Javier; Gomez, Henry; Hu, Xichun; Jhaveri, Komal; Krivorotko, Petr; Loibl, Sibylle; Murillo, Serafin Morales; Okera, Meena; Park, Yeon; Sohn, Joo Hyuk; Toi, Masakazu; Tokunaga, Eriko; Zhukova, Lyudmila; Lloyd, Andrew; de Bruin, Elza; Egile, Coumaran; D'Cruz, Celina; Turner, Nicholas
HER2-positive early breast cancer (EBC): treatment, toxicities and outcomes in a retrospective cohort of elderly patients (pts)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Rezqallah, Alejandra; Gomez-Puerto, Diego; Ranchor, Ridhi; Joval-Ramentol, Laia; Sanz, Lucia; Borrell, Maria; Alvarado-Cardenas, Marcelo; San-Jose, Antonio; Comas, Clara Morales; Espinosa-Bravo, Martin; Altabas, Manuel; Zamora, Esther; Ortiz, Carolina; Pardo, Patricia Gomez; Pimentel, Isabel; Bellet-Ezquerra, Meritxell; Oliveira, Mafalda; Saura, Cristina; Arumi, Miriam; Escriva-De-Romani, Santiago

研究方向

暂未获取到该数据
C
Cristina Saura
H 指数:61论文数:740被引数:1.8万
A
Aleix Prat
H 指数:92论文数:1,351被引数:3.6万
J
Javier Cortés
H 指数:113论文数:1,481被引数:6.8万
T
Tomás Pascual
H 指数:35论文数:449被引数:5,508
P
Patricia Villagrasa
H 指数:28论文数:207被引数:3,487
E
Eva Ciruelos
H 指数:54论文数:695被引数:1.9万
L
Laia Paré
H 指数:43论文数:431被引数:7,300
P
Paolo Nucíforo
H 指数:70论文数:840被引数:1.9万
P
Patricia Galván
H 指数:37论文数:313被引数:6,539
M
María Vidal
H 指数:43论文数:425被引数:1.1万